Home › Funds › Canaan Partners XI LLC › TYRA
Canaan Partners XI LLC position in TYRA
TYRA BIOSCIENCES INC · Health Care
Canaan Partners XI LLC reported holding 750,000 shares of TYRA (TYRA BIOSCIENCES INC) in its Q3 2026 13F filing — a position valued at US$16.4M, representing 24.51% of its reported portfolio and ranking #2 among its reported holdings. Canaan Partners XI LLC has disclosed TYRA holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Canaan Partners XI LLC's TYRA position evolved
Canaan Partners XI LLC first disclosed a stake in TYRA in Q3 2023 at 4,409,991 shares (US$60.7M). The position peaked in Q3 2024 at 4,409,991 shares, worth US$103.7M. Across 13 filings, Canaan Partners XI LLC increased the stake 0 time(s), trimmed it 5 time(s) and left it unchanged 7 time(s). The most recent filing (Q3 2026) shows 750,000 shares valued at US$16.4M. Notable position changes include a 78% trim in Q1 2026 (shares fell 17% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 4.41M | $60.73M | New |
| Q4 2023 | 4.41M | $61.08M | Hold |
| Q1 2024 | 4.41M | $72.32M | Hold |
| Q2 2024 | 4.41M | $70.52M | Hold |
| Q3 2024 | 4.41M | $103.68M | Hold |
| Q4 2024 | 4.18M | $58.10M | Reduce |
| Q1 2025 | 4.14M | $38.54M | Reduce |
| Q2 2025 | 3.61M | $34.53M | Reduce |
| Q3 2025 | 3.61M | $50.48M | Hold |
| Q4 2025 | 3.37M | $88.71M | Reduce |
| Q1 2026 | 750.00K | $28.73M | Reduce |
| Q2 2026 | 750.00K | $23.95M | Hold |
| Q3 2026 | 750.00K | $16.40M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About TYRA and 13F data
TYRA (TYRA BIOSCIENCES INC) is a Health Care company. 48 other funds we track also report a position in TYRA — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$389.6M), Alta Partners Management Company, L.P. (US$122.1M), Nextech Invest Ltd. (US$113.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding TYRA
- RA CAPITAL MANAGEMENT, L.P. 12.20M sh · $389.62M · Q2 2026
- Alta Partners Management Company, L.P. 3.82M sh · $122.12M · Q2 2026
- Nextech Invest Ltd. 3.55M sh · $113.50M · Q2 2026
- TCG Crossover Management, LLC 3.25M sh · $103.77M · Q2 2026
- Siren, L.L.C. 3.40M sh · $74.27M · Q3 2026
- Commodore Capital LP 1.88M sh · $59.89M · Q2 2026
- Paradigm Biocapital Advisors LP 1.83M sh · $58.41M · Q2 2026
- BVF INC/IL 1.48M sh · $47.15M · Q2 2026
- 5AM Venture Management, LLC 1.03M sh · $32.88M · Q2 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 1.02M sh · $32.48M · Q2 2026
- Caligan Partners LP 806.99K sh · $25.78M · Q2 2026
- Sio Capital Management, LLC 695.32K sh · $22.21M · Q2 2026
More on Canaan Partners XI LLC
FAQ
How long has Canaan Partners XI LLC held TYRA?
Canaan Partners XI LLC has disclosed TYRA holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Canaan Partners XI LLC's current position in TYRA?
As of Q3 2026, Canaan Partners XI LLC holds 750.00K shares of TYRA (TYRA BIOSCIENCES INC), valued at $16.40M, representing 24.51% of its reported portfolio and ranking #2.
Has Canaan Partners XI LLC been buying or selling TYRA?
In the latest 13F filing (Q3 2026), Canaan Partners XI LLC held unchanged its position in TYRA. The position peaked in Q3 2024 at 4.41M shares.
Which other funds hold TYRA?
Other major institutional holders of TYRA include RA CAPITAL MANAGEMENT, L.P., Alta Partners Management Company, L.P., Nextech Invest Ltd., among 48 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.